Drug hypersensitivity: Pharmacogenetics and clinical syndromes

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 3 SUPPL., 2011, Pages

  Phillips, Elizabeth J ^a,b,c,d,h   Chung, Wen Hung ^e   Mockenhaupt, Maja ^f   Roujeau, Jean Claude ^g   Mallal, Simon A ^a,b  

^a MURDOCH UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h Institute for Immunology and Infectious Diseases Discovery Way ^*  (Australia)

Author keywords

abacavir; allopurinol; carbamazepine; Drug hypersensitivity; drug reaction with eosinophilia and systemic symptoms; drug induced hypersensitivity syndrome; nevirapine; pharmacogenetics; severe cutaneous adverse reaction; Stevens Johnson syndrome toxic epidermal necrolysis

Indexed keywords

ABACAVIR; ALLOPURINOL; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; DNA; FLUCLOXACILLIN; HLA B ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEVIRAPINE; OXCARBAZEPINE; PHENYTOIN;

ASIAN; CAUCASIAN; CHINESE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRESS SYNDROME; DRUG HYPERSENSITIVITY; EOSINOPHILIA; ETHNIC GROUP; GENETIC SCREENING; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY REACTION; IMMUNOPATHOGENESIS; LIVER DISEASE; PATCH TEST; PHARMACOGENETICS; PREDICTIVE VALUE; PRIORITY JOURNAL; RASH; SCREENING TEST; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SYMPTOM; TOXIC EPIDERMAL NECROLYSIS;

ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; DRUG HYPERSENSITIVITY; ENZYME INHIBITORS; EOSINOPHILIA; FEMALE; GENETIC TESTING; HLA-B ANTIGENS; HUMANS; MALE; SKIN DISEASES;

EID: 79952175796     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.11.046     Document Type: Conference Paper

References (47)

1. S.L. Hung, W.H. Chung, L.B. Liou, C.C. Chu, M. Lin, and H.P. Huang HLA-B5801 allele as a genetic marker for severe cutaneous advers (Pubitemid 40388568)
2. N. Kaniwa, Y. Saito, M. Aihara, K. Matsunaga, M. Tohkin, and K. Kurose HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis Pharmacogenomics 9 2008 1617 1622
3. W. Tassaneeyakul, T. Jantararoungtong, P. Chen, P.Y. Lin, S. Tiamkao, and U. Khunarkornsiri Strong association between HLA-B5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Pharmacogenet Genomics 19 2009 704 709
4. C. Lonjou, N. Borot, P. Sekula, N. Ledger, L. Thomas, and S. Halevy A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs Pharmacogenet Genomics 18 2008 99 107
5. W.H. Chung, S.I. Hung, H.S. Hong, M.S. Hsih, L.C. Yang, and H.C. Ho Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486
6. C.B.L. Man, P. Kwan, L. Baum, E. Yu, K.M. Lau, and A.S.H. Cheng Association between HLA-B1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese Epilepsia 48 2007 1015 1018 (Pubitemid 46763406)
7. C. Locharernkul, J. Loplumlert, C. Limotai, W. Korkij, T. Desudchit, and S. Tongkobpetch Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B1502 allele in Thai population Epilepsia 49 2008 2087 2091
8. Chang C, Too C, Murad S, Hussein S. Association of HLA-B1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in Malaysian populations. In: Proceedings of the 7th Asian-Oceanian Epilepsy Congress; 2008; Xiamen, China.
9. T.Y. Mehta, L.M. Prajapati, B. Mittal, C.G. Joshi, J.J. Sheth, and D.B. Patel Association of HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians Indian J Dermatol Venereol Leprol 75 2009 579 582
10. H. Ikeda, Y. Takahashi, E. Yamazaki, T. Fujiwara, N. Kaniwa, and Y. Saito HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions Epilepsia 51 2010 297 300
11. S.I. Hung, W.H. Chung, Z.S. Liu, C.H. Chen, M.S. Hsih, and R.C.Y. Hui Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese Pharmacogenomics 11 2010 349 356
12. S. Mallal, D. Nolan, C. Witt, G. Masel, A.M. Martin, and C. Moore Association between presence of HLA-B5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Lancet 359 2002 727 732 (Pubitemid 34215071)
13. S. Hetherington, A.R. Hughes, M. Mosteller, D. Shortino, K.L. Baker, and W. Spreen Genetic variations in HLA-B region and hypersensitivity reactions to abacavir Lancet 359 2002 1121 1122 (Pubitemid 34270738)
14. S. Mallal, E. Phillips, G. Carosi, J.M. Molina, C. Workman, and J. Tomazic HLA-B5701 screening for hypersensitivity to abacavir N Engl J Med 358 2008 568 579
15. M.S. Saag, R. Balu, E. Phillips, P. Brachman, C. Martorell, and W. Burman High sensitivity of human leukocyte antigen-B5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients Clin Infect Dis 46 2008 1111 1118 (Pubitemid 351589880)
16. A.M. Martin, D. Nolan, I. James, P. Cameron, J. Keller, and C. Moore Predisposition to nevirapine hypersensitivity associated with HLA-DRB10101 and abrogated by low CD4 T-cell counts AIDS 19 2005 97 99 (Pubitemid 40111026)
17. R. Littera, C. Carcassi, A. Masala, P. Piano, P. Serra, and F. Ortu HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients AIDS 20 2006 1621 1626 (Pubitemid 44162404)
18. H. Gatanaga, H. Yazaki, J. Tanuma, M. Honda, I. Genka, and K. Teruya HLA-Cw8 primarily associated with hypersensitivity to nevirapine AIDS 21 2007 264 265 (Pubitemid 46036947)
19. S. Chantarangsu, T. Mushiroda, S. Mahasirimongkol, S. Kiertiburanakul, S. Sungkanuparph, and W. Manosuthi HLA-B 3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients Pharmacogenet Genomics 19 2009 139 146
20. E. Phillips, M. Lucas, N. Kean, A. Lucas, E. McKinnon, and S. Mallal HLA-B35 is associated with nevirapine hypersensitivity in the contemporary Western Australian HIV cohort study Eur Ann Allergy Clin Immunol 42 2010 48
21. E.J. Phillips, J.R. Sullivan, S.R. Knowles, and N.H. Shear Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir AIDS 16 2002 2223 2225 (Pubitemid 35387279)
22. E.J. Phillips, G.A. Wong, R. Kaul, K. Shahabi, D.A. Nolan, and S.R. Knowles Clinical and immunogenetic correlates of abacavir hypersensitivity AIDS 19 2005 979 981 (Pubitemid 40834943)
23. N.H. Shear, B. Milpied, D.P. Bruynzeel, and E.J. Phillips A review of drug patch testing and implications for HIV clinicians AIDS 22 2008 999 1007 (Pubitemid 351769738)
24. E.J. Phillips, and S.A. Mallal Pharmacogenetics of drug hypersensitivity Pharmacogenomics 11 2010 973 987
25. A.R. Hughes, M. Mosteller, A.T. Bansal, K. Davies, S.A. Haneline, and E.H. Lai Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations Pharmacogenomics 5 2004 203 211 (Pubitemid 38351278)
26. Genotype based personalized prescription of nevirapine (GENPART) NCT00986063. Available at: www.clinicaltrails.gov. Accessed June 11, 2010.
27. J.C. Roujeau Clinical heterogeneity of drug hypersensitivity Toxicology 209 2005 123 129
28. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R. Stern, and T. Anderson Medication use and the risk of Stevens-Johnson syndrome or toxic dpiermal necrolysis N Eng J Med 333 1993 1600 1607
29. S. Bastuji-Garin, B. Rzany, R.S. Stern, N.H. Shear, L. Naldi, and J.C. Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 1993 92 96 (Pubitemid 23029676)
30. A. Sidoroff, S. Halevy, J.N.B. Bavinck, L. Vaillant, and J.C. Roujeau Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern J Cutan Pathol 28 2001 113 119 (Pubitemid 32112994)
31. S.H. Kardaun, A. Sidoroff, L. Valeyrie-Allanore, S. Halevy, B.B. Davidovici, and M. Mockenhaupt Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156 2007 609 611
32. A. Auquier-Dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder, and J.C. Roujeau Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: Results of an international prospective study Arch Dermatol 138 2002 1019 1024 (Pubitemid 34875605)
33. S.H. Kardaun, P. Sekula, M. Mockenhaupt, C.Y. Chu, D. Creamer, and A. Sidoroff Drug reaction with eosinophilia and systemic symptoms (DRESS): results from the RegiSCAR Eur Ann Allergy Clin Immunol 42 2010 45
34. M. Mockenhaupt Epidemiology and causes of severe cutaneous adverse reactions to drugs W.J. Pichler, Drug hypersensitivity 2007 Karger Basel 18 31
35. K.E. Lasser, P.D. Allen, S.J. Woolhandler, D.U. Himmelstein, S.M. Wolfe, and D.H. Bor Timing of new black box warnings and withdrawals for prescription medications JAMA 287 2002 2215 2220 (Pubitemid 34441937)
36. W.H. Chung, S.I. Hung, and Y.T. Chen Genetic predisposition of life-threatening antiepileptic-induced skin reactions Expert Opin Drug Saf 9 2010 15 21
37. S.I. Hung, W.H. Chung, S.H. Jee, W.C. Chen, Y.T. Chang, and W.R. Lee Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet Genomics 16 2006 297 306
38. C. Lonjou, L. Thomas, N. Borot, N. Ledger, C. deToma, and H. LeLouet A marker for Stevens-Johnson syndrome: ethnicity matters Pharmacogenomics J 6 2006 265 268 (Pubitemid 44137953)
39. T. Dainichi, H. Uchi, Y. Moroi, and M. Furue Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity? Dermatology 215 2007 86 88 (Pubitemid 46976024)
40. B.M. Kuehn FDA: epilepsy drugs may carry skin risks for Asians JAMA 300 2008 2845
41. W.H. Chung, S.I. Hung, J.Y. Yang, S.C. Su, S.P. Huang, and C.Y. Wei Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis Nat Med 14 2008 1343 1350
42. Chen P, Shen C, Lin J, Ong C, Wu S, Tsai P, et al. A prospective study of HLA-B1502 genotyping in preventing carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis [abstract 305]. Presented at: 59th Annual Meeting of the American Society of Human Genetics; October 20-24, 2009; Honolulu, Hawaii.
43. S. Halevy, P.D. Ghislain, M. Mockenhaupt, J.P. Fagot, J.N. Bouwes Bavinck, and A. Sidoroff Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel J Am Acad Dermatol 58 2008 25 32 (Pubitemid 350298142)
44. R.M. Gueant-Rodriguez, J.L. Gueant, M. Viola, D. Tramoy, F. Gaeta, and A. Romano Association of tumor necrosis factor-alpha-308G>A polymorphism with IgE-mediated allergy to beta-lactams in an Italian population Pharmacogenomics J 8 2008 162 168 (Pubitemid 351418952)
45. L. Guglielmi, C. Fontaine, C. Gougat, O. Avinens, J.F. Eliaou, P. Guglielmi, and P. Demoly IL-10 promoter and ILF4-Ralpha gene single nucleotide polymorphisms are associated with immediate beta-lactam allergy in atopic women Allergy 61 2006 932 937
46. R.M. Gueant-Rodriguez, A. Romano, M. Beri-Dexheimer, M. Viola, F. Gaeta, and J.L. Gueant Gene-gene interactions of IL13 and IL4RA variants in immediate allergic reactions to beta lactam antibiotics Pharmacogenet Genomics 16 2006 713 719 (Pubitemid 44454865)
47. H.L. Qiao, J. Yang, and Y.W. Zhang Specific serum IgE levels and FcepsilonRI beta genetic polymorphism in patients with penicillins allergy Allergy 59 2004 1326 1332 (Pubitemid 39506732)